Top Section/Ad
Top Section/Ad
Most recent
Noba Bank block trade is first from 2025's IPO crop
Barrick confirms plans to spin off its North American gold assets
Commodities trader halves its stake for £132m after shares soar
More articles/Ad
More articles/Ad
More articles
-
Narayana Hrudayalaya has continued the stellar run of healthcare-themed IPOs in India with its Rp6.13bn ($92m) listing, which priced on Wednesday at the top of the indicative range. -
Indian pharmaceutical company Strides Shasun Arcolabs has priced a qualified institutional placement — which raised Rp11.03bn ($166.4m) — below its floor price, according to a filing with India’s National Stock Exchange on Monday.
-
Asia’s equity capital market is beginning to wind down after enduring its most difficult period in years. As bankers turn the page on 2015 and some high profile trades get lined up for next year, market watchers are hoping that things won’t be so volatile in 2016. John Loh reports.
-
Alkem Laboratories is set to price its Rp13.5bn ($202.1m) IPO at the top of the range after investors piled into the trade, buoyed by healthy demand for the Indian pharmaceutical sector.
-
Ethos Private Equity sold in a block trade on Tuesday night its last shares in Transaction Capital, the Johannesburg-listed commercial finance company.
-
At this time of year, attention in the equity capital market is divided between avidly fighting for next year’s mandates, which are beginning to mount up — and counting the spoils from this year. Has it been a good, bad or indifferent year — and for whom?
